Clinical trial
Post-Acute Sequelae of Coronavirus-19 (COVID-19) With DysPnEA on ExertIon And Associated TaChycardia TrEatment Study
NCT05096884 is registered in ClinicalTrials.gov with Hackensack Meridian Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Acute Sequelae of Coronavirus-19 (COVID-19) With DysPnEA on ExertIon And Associated TaChycardia TrEatment Study
- Lead sponsor
- Hackensack Meridian Health
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- March 23, 2022
- Completion date
- September 12, 2023
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.